Title : Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers.

Pub. Date : 2011 Feb

PMID : 21219297






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HSP90 inhibition is a promising strategy in MM especially in combination with bortezomib; additional studies will further evaluate optimal dosings of candidate drugs and schedules, as well as confirm efficacy in comparative phase III trials. Bortezomib heat shock protein 90 alpha family class A member 1 Homo sapiens